Conditions: Stress Urinary Incontinence
Keywords: Phase 2 stress urinary incontinence Fesoterodine
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 22
Healthy volunteers: no

Brief summary:
The hypothesis under evaluation is that fesotorodine may provide clinical benefit in the treatment of the condition of stress urinary incontinence

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Fesoterodine
Intervention descriptions: intervention 1: Fesoterodine 4 mg and 8 mg and placebo - each dosed for 7 days with 7 day washout between dosing periods

Protocol document: